Streetbeat News

Stock Prices

LI

NIO

XPEV

Chinese EV stocks NIO, XPeng, and Li Auto are trading higher due to China's cash-for-clunkers program, which could boost EV sales to over 10 million in 2024. Despite recent stock declines, the program's incentives may drive significant revenue growth.

Portfolio Pulse from Anusuya Lahiri

August 19, 2024 | 1:55 pm

ALZN

Alzamend Neuro's shares were halted due to a circuit breaker as the stock surged by 530.9%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:53 pm

ALZN

Alzamend Neuro shares have resumed trading after a temporary halt. This development is significant for investors as it may impact the stock's short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:51 pm

ALZN

Alzamend Neuro's shares were halted due to a circuit breaker as the stock surged by 347.1%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:49 pm

CING

Cingulate has increased the maximum offering price for its common stock under its sales agreement from $8.47 million to $11.33 million. The company filed a prospectus supplement for an additional $2.86 million of shares, having already sold shares worth $8.47 million.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:48 pm

BTCUSD

Institutional investors are increasingly adopting Bitcoin ETFs, with a 30% rise in Q2 filings despite market volatility. This trend indicates strong institutional interest and resilience, as many investors maintained or increased their holdings.

Portfolio Pulse from Murtuza Merchant

August 19, 2024 | 1:46 pm

SOND

Sonder shares have resumed trading, which could indicate a resolution of previous issues that halted trading. Investors should monitor the situation closely for further developments.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:41 pm

ALZN

Alzamend Neuro Inc. (NASDAQ:ALZN) stock surged after announcing a partnership with Massachusetts General Hospital for a Phase 2 study of AL001 for PTSD treatment. The study aims to assess lithium levels in the brain compared to marketed lithium salts. Alzamend hopes to meet FDA safety standards through the Section 505(b)(2) pathway.

Portfolio Pulse from Vandana Singh

August 19, 2024 | 1:41 pm

XPEV

XPeng Inc (NYSE:XPEV) is facing bearish signals ahead of its Mona M03 launch on Aug. 27, following its Q2 earnings report on Aug. 20. The stock is down over 50% YTD and is trading below key moving averages, indicating a downward trend. Analysts see a potential 26.23% upside with a price target of $9.

Portfolio Pulse from Surbhi Jain

August 19, 2024 | 1:36 pm

SOND

Sonder shares experienced a significant surge, triggering a circuit breaker as the stock rose by 71%.

Portfolio Pulse from Benzinga Newsdesk

August 19, 2024 | 1:36 pm